ArticleCancers2024
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation.
Paolo De Simone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleCancers2024
Paolo De Simone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.